Cordant Inc’s Fresenius Medical Care FMS Stock Holding History

Cordant Inc’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-78	Closed	-$3K	–	103
2019 Q4	$3K	Buy	+78	New	+$2.77K	﹤0.01%	147

Other funds holding FMS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Cordant Inc's FMS Position: Q1 2020 in Review

Cordant Inc sold out of Fresenius Medical Care (FMS) in Q1 2020, closing a stake of 78 shares — an estimated $3K sold.

Cordant Inc first reported a position in FMS in Q4 2019 and held it in 1 quarter. The position peaked at $3K in Q4 2019. 177 funds tracked by Wall St. Rank hold FMS as of Q1 2020.

Cordant Inc reported no remaining Fresenius Medical Care position as of Q1 2020 after selling out during the quarter.
Cordant Inc sold 78 Fresenius Medical Care shares in Q1 2020, an estimated $3K.
Cordant Inc first reported a position in Fresenius Medical Care in Q4 2019 and held it in 1 quarter.
Cordant Inc's Fresenius Medical Care position peaked at $3K in Q4 2019.
177 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2020.

Based on Cordant Inc's 13F filing for Q1 2020, filed 18 Nov 2020.